🔗 Share this article

An underground economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these accounts directly for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with numerous of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer laws, risking penalties, prosecution or prison.

Platform Reaction and Content Elimination

According to TikTok, the service has removed violative content and prohibited related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Research also found groups with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, filled with photos of slimming results, glowing testimonials and detailed instructions for preparing or administering at home.

Within minutes of entering one community, a seller posted WhatsApp details, where the majority of purchases take place. The seller sent an guidebook and promised delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.

Product Information and Costs

Inside these communities, posts display dark colored packages with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled pens usually priced at £160 for 20mg. When questioned how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram said it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has previously seen individuals harmed by self-injection from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental product not yet authorized … may subject users to potentially serious health risks”.